Skip to content

P04.41

Billable

Newborn affected by maternal use of cocaine

Last updated: FY2026 ICD-10-CM (Oct 1, 2025 – Sep 30, 2026) | CMS-HCC V28 (100% phase-in, PY2026)

Is P04.41 an HCC code?

Yes. P04.41 maps to Drug Use Disorder/Substance Use Disorder, Moderate/Severe under the CMS-HCC V28 risk adjustment model.

HCC Category Mapping

V28HCC 137Drug Use Disorder/Substance Use Disorder, Moderate/Severe
0.358

RAF weights shown are the community, non-dual, aged base weights from the CMS risk adjustment model file. Actual per-patient RAF contribution depends on member segment, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains in use during the transition and for historical data.

MEAT Criteria for P04.41

For P04.41to count as a valid HCC diagnosis in a given encounter, the provider's documentation must show MEAT: Monitor, Evaluate, Assess, or Treat. A diagnosis from a prior year does not carry forward automatically — it has to be re-documented and supported each calendar year.

  • MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
  • EEvaluate: test results, medication response, or physical findings reviewed by the provider
  • AAssess: explicit mention in the assessment or plan with acknowledgment of status
  • TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis

Only one of M/E/A/T is required to support the code, but the documentation must be specific enough to show that the provider actually addressed P04.41 during that encounter — not just copy-forwarded from a problem list.

What This Code Means

P04.41 is the ICD-10-CM diagnosis code for newborn affected by maternal use of cocaine. A newborn experiencing withdrawal symptoms or other health effects from the mother's cocaine use during pregnancy, which can cause irritability, poor feeding, and developmental problems. P04.41 sits in the ICD-10-CM chapter for certain conditions originating in the perinatal period (p00-p96), within the section covering newborn affected by maternal factors and by complications of pregnancy, labor, and delivery (p00-p04).

Under the CMS-HCC V28 risk adjustment model, P04.41 maps to Drug Use Disorder/Substance Use Disorder, Moderate/Severe (HCC 137) with a community, non-dual, aged base RAF weight of 0.358. P04.41 was not retained as a payment HCC under the older V24 model, so V28 introduced or recategorized it during the 2024–2026 phase-in. V28 is the CMS-HCC risk adjustment model that reached 100% phase-in for payment year 2026, replacing V24 which was used during the PY2024–PY2025 transition.

Document specific newborn manifestations such as tremors, irritability, or feeding difficulties related to cocaine exposure. Because P04.41 maps to a payment HCC, the provider's documentation must satisfy MEAT criteria (Monitor, Evaluate, Assess, or Treat) for the encounter to count toward the patient's Medicare Advantage risk adjustment score. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.

HCC Buddy maintains structured V28 and V24 mapping, RAF weights, and MEAT documentation criteria for P04.41 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.

Coding Tips

  • Document specific newborn manifestations such as tremors, irritability, or feeding difficulties related to cocaine exposure
  • Distinguish between maternal cocaine use history and actual documented effects on the newborn's condition

Clinical Significance

Maternal cocaine use during pregnancy causes significant risks including placental abruption, premature delivery, and neonatal complications such as irritability, tremors, and feeding difficulties. These newborns require intensive monitoring and may need pharmacological treatment for withdrawal symptoms.

Documentation Requirements

  • Documentation of maternal cocaine use during pregnancy
  • Pattern and timing of cocaine use
  • Clinical signs of cocaine exposure in newborn
  • Evidence of withdrawal or abstinence syndrome
  • Neurological assessment and behavioral observations
  • Growth parameters and gestational age
  • Interventions provided for symptom management

Commonly Confused Codes

  • P04.16 — Newborn affected by maternal use of amphetamines (amphetamines vs cocaine)
  • P04.40 — Newborn affected by maternal use of unspecified drugs of addiction
  • P96.1 — Neonatal withdrawal symptoms from maternal drug use
  • P91.60 — Hypoxic ischemic encephalopathy, unspecified

Code Hierarchy

Open P04.41 in the Interactive Encoder

See full code details, AI coding tips, HCC mappings, and related codes in our interactive encoder. Start your 14-day Pro trial — no credit card required.